Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pueyo, M. E.
Right arrow Articles by Jacob, M.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pueyo, M. E.
Right arrow Articles by Jacob, M.-P.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:1111-1118, 2004
© 2004 by the American Diabetes Association, Inc.

Transforming Growth Factor-ß1 Production Is Correlated With Genetically Determined ACE Expression in Congenic Rats

A Possible Link Between ACE Genotype and Diabetic Nephropathy

Maria E. Pueyo1,2, Mireille Challah1, Dominique Gauguier3, Liliane Louedec1, Monique Philippe1, Roger Gaertner1, Michel Marre2,4, Jean-Baptiste Michel1, and Marie-Paule Jacob1

1 INSERM U460, CHU Bichat, Paris, France
2 Service de Diabetologie, CHU Bichat, Paris, France
3 The Welcome Trust Centre for Human Genetics, Oxford, U.K
4 EA 3516, University Paris VII, Paris, France

Genetic background appears to modulate the development of diabetic vascular complications. In particular, polymorphisms in the ACE gene have been associated with diabetic nephropathy and, in some studies, macrovascular complications. However, the links between ACE gene polymorphism and factors implicated in diabetes complications remain unknown. The aim of this study was to determine whether the ACE genotype could modify factors, such as transforming growth factor (TGF)-ß1, involved in the complications of diabetes. For this purpose, congenic rats (L.BNAce10), differing from the LOU strain in only a small segment of chromosome 10 containing the ACE locus, were generated. These congenic rats have plasma ACE levels twice as high as the donor strain. Diabetes was induced in rats of both strains, and its effects on ACE and TGF-ß1 expressions were evaluated in lungs and kidneys. In lung, the main source of ACE production, ACE mRNA levels and activity were higher in L.BNAce10 rats than in LOU rats. Diabetes increased ACE lung expression in rats of both strains in a similar manner. TGF-ß1 expression was also higher in lungs of L.BNAce10 compared with LOU rats and was also increased by diabetes. Furthermore, a strong correlation was found between TGF-ß1 and ACE expressions. In renal arterioles, ACE and TGF-ß mRNA expressions were higher in L.BNAce10 rats than LOU rats (both diabetic and nondiabetic). In these vessels, there was also a correlation between ACE and TGF-ß1 expressions. Urine TGF-ß1 concentration depended on the genotype and was further increased by diabetes. These results show that TGF-ß1 expression is correlated with ACE expression and suggest that this growth factor could be a link between ACE gene polymorphism and diabetic vascular complications.

Address correspondence and reprint requests to Maria E. Pueyo, INSERM U460, CHU Bichat, Claude Bernard, 46, rue Henri Huchard, 75018 Paris, France. E-mail: u460{at}bichat.inserm.fr


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.